Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5397
-0.0556 %
$ 23 M
Market Cap
-3.17
P/E
ADAP - COMMON STOCK
Common Stock ADAP - Adaptimmune Therapeutics plc
1.86 M
LAST VALUE
18.11%
2 YEAR CAGR
14.71%
5 YEAR CAGR
103.65%
10 YEAR CAGR